The FDA has approved semaglutide and tirzepatide for chronic weight management in adults with obesity or in overweight adults with at least one weight-related health condition
Similar to quickly showing a person with diabetes how a GLP-1 is working in their body (affecting glucose responses), CGM data provides the doctor with valuable insights into how the medication is working as they start, change, or increase the GLP-1 dose
With proper medical care, including hormone replacement therapy and lifestyle changes, many individuals achieve significant improvements
GLP-1 receptors the docking points where GLP-1 attaches and delivers its message are found not just in the pancreas, but also in specific regions of the brain that control hunger, fullness, and food cravings
When it comes to bioavailability, liposomal glutathione offers a lot of promise that we hope will be proven in the future
Frequently Asked Questions Does Mounjaro directly cause menstrual irregularities